Drug-Induced Subacute Cutaneous Lupus Erythematosus Secondary to Dupilumab: A Case Report
January 2024
in “
SAGE Open Medical Case Reports
”
Studysummary In this case report, a 63-year-old male with rheumatoid arthritis, diabetes, hypertension, and peripheral neuropathy developed drug-induced subacute cutaneous lupus erythematosus after taking Dupilumab for chronic hand dermatitis.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
A 63-year-old male with a medical history of rheumatoid arthritis, diabetes, hypertension, and peripheral neuropathy developed drug-induced subacute cutaneous lupus erythematosus as a result of taking Dupilumab for chronic hand dermatitis. This case highlights the potential for Dupilumab, a medication typically used for dermatitis, to induce lupus erythematosus, emphasizing the need for careful monitoring of patients receiving this treatment.
